Geode Capital Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Geode Capital Management's JANX Position: Q3 2026 in Review
Geode Capital Management increased its Janux Therapeutics (JANX) stake by 6.4% in Q3 2026, buying an estimated $1.29M and bringing the position to 1,281,018 shares worth $22.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2051.
Geode Capital Management first reported a position in JANX in Q2 2021 and has held it in 22 quarters since. The position peaked at $38.3M in Q4 2024. 139 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Geode Capital Management held 1,281,018 shares of Janux Therapeutics worth $22.1M as of Q3 2026.
- Geode Capital Management bought 76,868 Janux Therapeutics shares in Q3 2026, an estimated $1.29M.
- Janux Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2051 holding.
- Geode Capital Management first reported a position in Janux Therapeutics in Q2 2021 and has held it in 22 quarters since.
- Geode Capital Management's Janux Therapeutics position peaked at $38.3M in Q4 2024.
- 139 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.